313 related articles for article (PubMed ID: 26994145)
21. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
[TBL] [Abstract][Full Text] [Related]
22. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.
Hayashi H; Tanishima S; Fujii K; Mori R; Okada C; Yanagita E; Shibata Y; Matsuoka R; Amano T; Yamada T; Yabe I; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Cancer Sci; 2020 Oct; 111(10):3926-3937. PubMed ID: 32772458
[TBL] [Abstract][Full Text] [Related]
24. Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Sholler GLS; Bergendahl G; Lewis EC; Kraveka J; Ferguson W; Nagulapally AB; Dykema K; Brown VI; Isakoff MS; Junewick J; Mitchell D; Rawwas J; Roberts W; Eslin D; Oesterheld J; Wada RK; Pastakia D; Harrod V; Ginn K; Saab R; Bielamowicz K; Glover J; Chang E; Hanna GK; Enriquez D; Izatt T; Halperin RF; Moore A; Byron SA; Hendricks WPD; Trent JM
Genome Med; 2024 Feb; 16(1):28. PubMed ID: 38347552
[TBL] [Abstract][Full Text] [Related]
25. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
[TBL] [Abstract][Full Text] [Related]
26. Somatic and Germline
Sherborne AL; Lavergne V; Yu K; Lee L; Davidson PR; Mazor T; Smirnoff IV; Horvai AE; Loh M; DuBois SG; Goldsby RE; Neglia JP; Hammond S; Robison LL; Wustrack R; Costello JF; Nakamura AO; Shannon KM; Bhatia S; Nakamura JL
Clin Cancer Res; 2017 Apr; 23(7):1852-1861. PubMed ID: 27683180
[No Abstract] [Full Text] [Related]
27. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
[TBL] [Abstract][Full Text] [Related]
28. Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Byron SA; Hendricks WPD; Nagulapally AB; Kraveka JM; Ferguson WS; Brown VI; Eslin DE; Mitchell D; Cornelius A; Roberts W; Isakoff MS; Oesterheld JE; Wada RK; Rawwas J; Neville K; Zage PE; Harrod VL; Bergendahl G; VanSickle E; Dykema K; Bond J; Chou HC; Wei JS; Wen X; Reardon HV; Roos A; Nasser S; Izatt T; Enriquez D; Hegde AM; Cisneros F; Christofferson A; Turner B; Szelinger S; Keats JJ; Halperin RF; Khan J; Saulnier Sholler GL; Trent JM
Cancer Res; 2021 Dec; 81(23):5818-5832. PubMed ID: 34610968
[TBL] [Abstract][Full Text] [Related]
29. An update on genomic-guided therapies for pediatric solid tumors.
Tsui PC; Lee YF; Liu ZWY; Ip LRH; Piao W; Chiang AKS; Lui VWY
Future Oncol; 2017 Jun; 13(15):1345-1358. PubMed ID: 28589766
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
Summers RJ; Castellino SM; Porter CC; MacDonald TJ; Basu GD; Szelinger S; Bhasin MK; Cash T; Carter AB; Castellino RC; Fangusaro JR; Mitchell SG; Pauly MG; Pencheva B; Wechsler DS; Graham DK; Goldsmith KC
JCO Precis Oncol; 2022 Apr; 6():e2100451. PubMed ID: 35544730
[TBL] [Abstract][Full Text] [Related]
31. Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution.
Park HS; Lim SM; Kim S; Kim S; Kim HR; Kwack K; Lee MG; Kim JH; Moon YW
PLoS One; 2016; 11(4):e0154133. PubMed ID: 27105424
[TBL] [Abstract][Full Text] [Related]
32. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.
Ghazani AA; Oliver NM; St Pierre JP; Garofalo A; Rainville IR; Hiller E; Treacy DJ; Rojas-Rudilla V; Wood S; Bair E; Parello M; Huang F; Giannakis M; Wilson FH; Stover EH; Corsello SM; Nguyen T; Rana HQ; Church AJ; Lowenstein C; Cibulskis C; Amin-Mansour A; Heng J; Brais L; Santos A; Bauer P; Waldron A; Lo P; Gorman M; Lydon CA; Welch M; McNamara P; Gabriel S; Sholl LM; Lindeman NI; Garber JE; Joffe S; Van Allen EM; Gray SW; Ja Nne PA; Garraway LA; Wagle N
Genet Med; 2017 Jul; 19(7):787-795. PubMed ID: 28125075
[TBL] [Abstract][Full Text] [Related]
33. Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.
Ramkissoon SH; Bandopadhayay P; Hwang J; Ramkissoon LA; Greenwald NF; Schumacher SE; O'Rourke R; Pinches N; Ho P; Malkin H; Sinai C; Filbin M; Plant A; Bi WL; Chang MS; Yang E; Wright KD; Manley PE; Ducar M; Alexandrescu S; Lidov H; Delalle I; Goumnerova LC; Church AJ; Janeway KA; Harris MH; MacConaill LE; Folkerth RD; Lindeman NI; Stiles CD; Kieran MW; Ligon AH; Santagata S; Dubuc AM; Chi SN; Beroukhim R; Ligon KL
Neuro Oncol; 2017 Jul; 19(7):986-996. PubMed ID: 28104717
[TBL] [Abstract][Full Text] [Related]
34. Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.
Nagashima T; Yamaguchi K; Urakami K; Shimoda Y; Ohnami S; Ohshima K; Tanabe T; Naruoka A; Kamada F; Serizawa M; Hatakeyama K; Matsumura K; Ohnami S; Maruyama K; Mochizuki T; Kusuhara M; Shiomi A; Ohde Y; Terashima M; Uesaka K; Onitsuka T; Nishimura S; Hirashima Y; Hayashi N; Kiyohara Y; Tsubosa Y; Katagiri H; Niwakawa M; Takahashi K; Kashiwagi H; Nakagawa M; Ishida Y; Sugino T; Takahashi M; Akiyama Y
Cancer Sci; 2020 Feb; 111(2):687-699. PubMed ID: 31863614
[TBL] [Abstract][Full Text] [Related]
35. Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing.
Schwaederle M; Chattopadhyay R; Kato S; Fanta PT; Banks KC; Choi IS; Piccioni DE; Ikeda S; Talasaz A; Lanman RB; Bazhenova L; Kurzrock R
Cancer Res; 2017 Oct; 77(19):5419-5427. PubMed ID: 28807936
[TBL] [Abstract][Full Text] [Related]
36. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
37. Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
Parsons DW; Janeway KA; Patton DR; Winter CL; Coffey B; Williams PM; Roy-Chowdhuri S; Tsongalis GJ; Routbort M; Ramirez NC; Saguilig L; Piao J; Alonzo TA; Berg SL; Fox E; Hawkins DS; Abrams JS; Mooney M; Takebe N; Tricoli JV; Seibel NL;
J Clin Oncol; 2022 Jul; 40(20):2224-2234. PubMed ID: 35353553
[TBL] [Abstract][Full Text] [Related]
38. Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting.
Lee B; Tran B; Hsu AL; Taylor GR; Fox SB; Fellowes A; Marquis R; Mooi J; Desai J; Doig K; Ekert P; Gaff C; Herath D; Hamilton A; James P; Roberts A; Snyder R; Waring P; McArthur G
Intern Med J; 2018 Jul; 48(7):786-794. PubMed ID: 29607586
[TBL] [Abstract][Full Text] [Related]
39. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
40. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
